NDC11 16571080316
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 16571-0803-16 | 16571-0803 |
| 16571-803-16 | 16571-803 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zolmitriptan | ZOLMITRIPTAN | Rising Pharma Holdings, Inc. | 5fcdc5d6-38fa-458d-a581-4e3678a9e8fd | 2024-02-17 | Warnings, Adverse reactions | 16571-803-16 16571-803 16571080316 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.